MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION

Optimal two-stage designs for phase II clinical trials

1989 • 3,494 citations

One-Sample Multiple Testing Procedure for Phase II Clinical Trials

1982 • 987 citations

The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1961 • 685 citations

Bayesian sequential monitoring designs for single‐arm clinical trials with multiple outcomes

1995 • 277 citations

Practical Bayesian Guidelines for Phase IIB Clinical Trials

1994 • 227 citations

Designs for Group Sequential Phase II Clinical Trials

1987 • 136 citations

An optimal three‐stage design for phase II clinical trials

1994 • 120 citations

Bivariate Sequential Designs for Phase II Trials

1995 • 97 citations

Designs for Phase II Trials Allowing for a Trade-Off between Response and Toxicity

1996 • 83 citations

A Bayesian Approach to the Design of Phase II Clinical Trials

1988 • 62 citations